The Hippo-YAP Signaling Pathway in Osteoarthritis and Rheumatoid Arthritis

References

• Bijlsma JWJ, Berenbaum F, Lafeber FPJG. Osteoarthritis: an update with relevance for clinical practice. Lancet. 2011;377(9783):2115–2126. doi:10.1016/S0140-6736(11)60243-2
   PubMed Web of Science ®Google Scholar
• Glyn-Jones S, Palmer AJR, Agricola R, et al. Osteoarthritis. Lancet. 2015;386(9991):376–387. doi:10.1016/S0140-6736(14)60802-3
   PubMed Web of Science ®Google Scholar
• Litwic A, Edwards MH, Dennison EM, Cooper C. Epidemiology and burden of osteoarthritis. Br Med Bull. 2013;105:185–199. doi:10.1093/bmb/lds038
   PubMed Web of Science ®Google Scholar
• Mandl LA. Osteoarthritis year in review 2018: clinical. Osteoarthritis Cartilage. 2019;27(3):359–364. doi:10.1016/j.joca.2018.11.001
   PubMed Web of Science ®Google Scholar
• Goldring MB, Goldring SR. Osteoarthritis. J Cell Physiol. 2007;213(3):626–634. doi:10.1002/jcp.21258
   PubMed Web of Science ®Google Scholar
• Bian Q, Wang YJ, Liu SF, Li YP. Osteoarthritis: genetic factors, animal models, mechanisms, and therapies. Front Biosci. 2012;4(1):74–100. doi:10.2741/e361
   Google Scholar
• Burr DB, Gallant MA. Bone remodelling in osteoarthritis. Nat Rev Rheumatol. 2012;8(11):665–673. doi:10.1038/nrrheum.2012.130
   PubMed Web of Science ®Google Scholar
• Poole AR, Kobayashi M, Yasuda T, et al. Type II collagen degradation and its regulation in articular cartilage in osteoarthritis. Ann Rheum Dis. 2002;61(Suppl 2):ii78–81. doi:10.1136/ard.61.suppl_2.ii78
   PubMed Web of Science ®Google Scholar
• Huang K, Wu LD. Aggrecanase and aggrecan degradation in osteoarthritis: a review. J Int Med Res. 2008;36(6):1149–1160. doi:10.1177/147323000803600601
   PubMed Web of Science ®Google Scholar
• Choi MC, Jo J, Park J, Kang HK, Park Y. NF-kappaB signaling pathways in osteoarthritic cartilage destruction. Cells. 2019;9(1):8. doi:10.3390/cells9010008
   PubMedGoogle Scholar
• Goldring MB, Marcu KB. Cartilage homeostasis in health and rheumatic diseases. Arthritis Res Ther. 2009;11(3):224. doi:10.1186/ar2592
   PubMed Web of Science ®Google Scholar
• Malemud CJ. Inhibition of MMPs and ADAM/ADAMTS. Biochem Pharmacol. 2019;165:33–40. doi:10.1016/j.bcp.2019.02.033
   PubMed Web of Science ®Google Scholar
• Wei Y, Luo L, Gui T, et al. Targeting cartilage EGFR pathway for osteoarthritis treatment. Sci Transl Med. 2021;4:13.
   Google Scholar
• de Lange-Brokaar BJ, Ioan-Facsinay A, van Osch GJ, et al. Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review. Osteoarthritis Cartilage. 2012;20(12):1484–1499. doi:10.1016/j.joca.2012.08.027
   PubMed Web of Science ®Google Scholar
• Mathiessen A, Conaghan PG. Synovitis in osteoarthritis: current understanding with therapeutic implications. Arthritis Res Ther. 2017;19(1):18. doi:10.1186/s13075-017-1229-9
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhao M, Li W, et al. BMSC-derived small extracellular vesicles induce cartilage reconstruction of temporomandibular joint osteoarthritis via autotaxin-YAP signaling axis. Front Cell Dev Biol. 2021;9:656153. doi:10.3389/fcell.2021.656153
   PubMed Web of Science ®Google Scholar
• Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol. 2010;6(11):625–635. doi:10.1038/nrrheum.2010.159
   PubMed Web of Science ®Google Scholar
• Scanzello CR, Goldring SR. The role of synovitis in osteoarthritis pathogenesis. Bone. 2012;51(2):249–257. doi:10.1016/j.bone.2012.02.012
   PubMed Web of Science ®Google Scholar
• Redlich K, Smolen JS. Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat Rev Drug Discov. 2012;11(3):234–250. doi:10.1038/nrd3669
   PubMed Web of Science ®Google Scholar
• Smolen JS, Aletaha D, Barton A, et al. Rheumatoid arthritis. Nat Rev Dis Primers. 2018;4:18001. doi:10.1038/nrdp.2018.1
   PubMed Web of Science ®Google Scholar
• Johnson R, Halder G. The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat Rev Drug Discov. 2014;13(1):63–79. doi:10.1038/nrd4161
   PubMed Web of Science ®Google Scholar
• Juan WC, Hong W. Targeting the hippo signaling pathway for tissue regeneration and cancer therapy. Genes. 2016;3:7.
   Google Scholar
• Moya IM, Halder G. The Hippo pathway in cellular reprogramming and regeneration of different organs. Curr Opin Cell Biol. 2016;43:62–68. doi:10.1016/j.ceb.2016.08.004
   PubMed Web of Science ®Google Scholar
• Patel SH, Camargo FD, Yimlamai D. Hippo signaling in the liver regulates organ size, cell fate, and carcinogenesis. Gastroenterology. 2017;152(3):533–545. doi:10.1053/j.gastro.2016.10.047
   PubMed Web of Science ®Google Scholar
• Warren JSA, Xiao Y, Lamar JM. YAP/TAZ activation as a target for treating metastatic cancer. Cancers. 2018;4:10.
   Google Scholar
• Xu T, Wang W, Zhang S, Stewart RA, Yu W. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development. 1995;121(4):1053–1063. doi:10.1242/dev.121.4.1053
   PubMed Web of Science ®Google Scholar
• Tapon N, Harvey KF, Bell DW, et al. salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell. 2002;110(4):467–478. doi:10.1016/S0092-8674(02)00824-3
   PubMed Web of Science ®Google Scholar
• Kango-Singh M, Nolo R, Tao C, et al. Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila. Development. 2002;129(24):5719–5730. doi:10.1242/dev.00168
   PubMed Web of Science ®Google Scholar
• Harvey KF, Pfleger CM, Hariharan IK. The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell. 2003;114(4):457–467. doi:10.1016/S0092-8674(03)00557-9
   PubMed Web of Science ®Google Scholar
• Jia J, Zhang W, Wang B, Trinko R, Jiang J. The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis. Genes Dev. 2003;17(20):2514–2519. doi:10.1101/gad.1134003
   PubMed Web of Science ®Google Scholar
• Udan RS, Kango-Singh M, Nolo R, Tao C, Halder G. Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway. Nat Cell Biol. 2003;5(10):914–920. doi:10.1038/ncb1050
   PubMed Web of Science ®Google Scholar
• Samji P, Rajendran MK, Warrier VP, Ganesh A, Devarajan K. Regulation of Hippo signaling pathway in cancer: a MicroRNA perspective. Cell Signal. 2021;78:109858. doi:10.1016/j.cellsig.2020.109858
   PubMed Web of Science ®Google Scholar
• Lai ZC, Wei X, Shimizu T, et al. Control of cell proliferation and apoptosis by mob as tumor suppressor, mats. Cell. 2005;120(5):675–685. doi:10.1016/j.cell.2004.12.036
   PubMed Web of Science ®Google Scholar
• Huang J, Wu S, Barrera J, Matthews K, Pan D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell. 2005;122(3):421–434. doi:10.1016/j.cell.2005.06.007
   PubMed Web of Science ®Google Scholar
• Sudol M. Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product. Oncogene. 1994;9(8):2145–2152.
   PubMed Web of Science ®Google Scholar
• Kong H, Han JJ, Gorbachev D, Zhang XA. Role of the Hippo pathway in autoimmune diseases. Exp Gerontol. 2024;185:112336. doi:10.1016/j.exger.2023.112336
   Web of Science ®Google Scholar
• Cottini F, Hideshima T, Xu C, et al. Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers. Nat Med. 2014;20(6):599–606. doi:10.1038/nm.3562
   PubMed Web of Science ®Google Scholar
• Pearson JD, Huang K, Pacal M, et al. Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activity. Cancer Cell. 2021;39(8):1115–1134 e12. doi:10.1016/j.ccell.2021.06.016
   PubMed Web of Science ®Google Scholar
• Zheng B, Sun W, Yi K, et al. Integrated transcriptomic analysis reveals a distinctive role of YAP1 in extramedullary invasion and therapeutic sensitivity of multiple myeloma. Front Oncol. 2021;11:787814. doi:10.3389/fonc.2021.787814
   Web of Science ®Google Scholar
• Hanahan D. Hallmarks of Cancer: new Dimensions. Cancer Discov. 2022;12(1):31–46. doi:10.1158/2159-8290.CD-21-1059
   PubMed Web of Science ®Google Scholar
• Piccolo S, Panciera T, Contessotto P, Cordenonsi M. YAP/TAZ as master regulators in cancer: modulation, function and therapeutic approaches. Nat Cancer. 2023;4(1):9–26. doi:10.1038/s43018-022-00473-z
   PubMedGoogle Scholar
• Zheng A, Chen Q, Zhang L. The Hippo-YAP pathway in various cardiovascular diseases: focusing on the inflammatory response. Front Immunol. 2022;13:971416. doi:10.3389/fimmu.2022.971416
   Google Scholar
• Austin KM, Trembley MA, Chandler SF, et al. Molecular mechanisms of arrhythmogenic cardiomyopathy. Nat Rev Cardiol. 2019;16(9):519–537. doi:10.1038/s41569-019-0200-7
   PubMed Web of Science ®Google Scholar
• Heallen T, Zhang M, Wang J, et al. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science. 2011;332(6028):458–461. doi:10.1126/science.1199010
   PubMed Web of Science ®Google Scholar
• Chen SN, Gurha P, Lombardi R, Ruggiero A, Willerson JT, Marian AJ. The hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic cardiomyopathy. Circ Res. 2014;114(3):454–468. doi:10.1161/CIRCRESAHA.114.302810
   Web of Science ®Google Scholar
• Webb C, Upadhyay A, Giuntini F, et al. Structural features and ligand binding properties of tandem WW domains from YAP and TAZ, nuclear effectors of the Hippo pathway. Biochemistry. 2011;50(16):3300–3309. doi:10.1021/bi2001888
   Web of Science ®Google Scholar
• Lin KC, Park HW, Guan KL. Regulation of the hippo pathway transcription factor TEAD. Trends Biochem Sci. 2017;42(11):862–872. doi:10.1016/j.tibs.2017.09.003
   PubMed Web of Science ®Google Scholar
• Boopathy GTK, Hong W. Role of hippo pathway-YAP/TAZ signaling in Angiogenesis. Front Cell Dev Biol. 2019;7:49. doi:10.3389/fcell.2019.00049
   PubMed Web of Science ®Google Scholar
• Zhao B, Ye X, Yu J, et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 2008;22(14):1962–1971. doi:10.1101/gad.1664408
   PubMed Web of Science ®Google Scholar
• Li Z, Zhao B, Wang P, et al. Structural insights into the YAP and TEAD complex. Genes Dev. 2010;24(3):235–240. doi:10.1101/gad.1865810
   PubMed Web of Science ®Google Scholar
• Pantalacci S, Tapon N, Leopold P. The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila. Nat Cell Biol. 2003;5(10):921–927. doi:10.1038/ncb1051
   PubMed Web of Science ®Google Scholar
• Praskova M, Xia F, Avruch J. MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. Curr Biol. 2008;18(5):311–321. doi:10.1016/j.cub.2008.02.006
   PubMed Web of Science ®Google Scholar
• Misra JR, Irvine KD. The hippo signaling network and its biological functions. Annu Rev Genet. 2018;52(1):65–87. doi:10.1146/annurev-genet-120417-031621
   PubMedGoogle Scholar
• Nishioka N, Inoue K, Adachi K, et al. The hippo signaling pathway components lats and yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass. Dev Cell. 2009;16(3):398–410. doi:10.1016/j.devcel.2009.02.003
   PubMed Web of Science ®Google Scholar
• Mauviel A, Nallet-Staub F, Varelas X. Integrating developmental signals: a Hippo in the (path)way. Oncogene. 2012;31(14):1743–1756. doi:10.1038/onc.2011.363
   Web of Science ®Google Scholar
• Jiang L, Li J, Zhang C, Shang Y, Lin J. YAPmediated crosstalk between the Wnt and hippo signaling pathways (Review). Mol Med Rep. 2020;22(5):4101–4106. doi:10.3892/mmr.2020.11529
   Web of Science ®Google Scholar
• Zhao B, Wei X, Li W, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007;21(21):2747–2761. doi:10.1101/gad.1602907
   PubMed Web of Science ®Google Scholar
• Piersma B, Bank RA, Boersema M. Signaling in Fibrosis: TGF-beta, WNT, and YAP/TAZ Converge. Front Med. 2015;2:59. doi:10.3389/fmed.2015.00059
   PubMed Web of Science ®Google Scholar
• Lei QY, Zhang H, Zhao B, et al. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol Cell Biol. 2008;28(7):2426–2436. doi:10.1128/MCB.01874-07
   PubMed Web of Science ®Google Scholar
• Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF β-TRCP. Genes Dev. 2010;24(1):72–85. doi:10.1101/gad.1843810
   PubMed Web of Science ®Google Scholar
• Camargo FD, Gokhale S, Johnnidis JB, et al. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol. 2007;17(23):2054–2060. doi:10.1016/j.cub.2007.10.039
   PubMed Web of Science ®Google Scholar
• Dong J, Feldmann G, Huang J, et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell. 2007;130(6):1120–1133. doi:10.1016/j.cell.2007.07.019
   PubMed Web of Science ®Google Scholar
• Lee KP, Lee JH, Kim TS, et al. The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc Natl Acad Sci U S A. 2010;107(18):8248–8253. doi:10.1073/pnas.0912203107
   PubMed Web of Science ®Google Scholar
• Nishio M, Hamada K, Kawahara K, et al. Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice. J Clin Invest. 2012;122(12):4505–4518. doi:10.1172/JCI63735
   Web of Science ®Google Scholar
• Zhou D, Conrad C, Xia F, et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell. 2009;16(5):425–438. doi:10.1016/j.ccr.2009.09.026
   PubMed Web of Science ®Google Scholar
• Zhang N, Bai H, David KK, et al. The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev Cell. 2010;19(1):27–38. doi:10.1016/j.devcel.2010.06.015
   PubMed Web of Science ®Google Scholar
• Caire R, Audoux E, Courbon G, et al. YAP/TAZ: key players for rheumatoid arthritis severity by driving fibroblast like synoviocytes phenotype and fibro-inflammatory response. Front Immunol. 2021;12:791907. doi:10.3389/fimmu.2021.791907
   Web of Science ®Google Scholar
• Wang T, Wang Z, Qi W, Jiang G, Wang G. Possible future avenues for rheumatoid arthritis therapeutics: hippo pathway. J Inflamm Res. 2023;16:1283–1296. doi:10.2147/JIR.S403925
   Web of Science ®Google Scholar
• Du Y, Cui R, Tian N, Chen M, Zhang XL, Dai SM. Regulation of type I interferon signature by VGLL3 in the fibroblast-like synoviocytes of rheumatoid arthritis patients via targeting the Hippo pathway. Arthritis Res Ther. 2022;24(1):188. doi:10.1186/s13075-022-02880-0
   Web of Science ®Google Scholar
• Symons RA, Colella F, Collins FL, et al. Targeting the IL-6-Yap-Snail signalling axis in synovial fibroblasts ameliorates inflammatory arthritis. Ann Rheum Dis. 2022;81(2):214–224. doi:10.1136/annrheumdis-2021-220875
   Web of Science ®Google Scholar
• Chen Q, Fan K, Chen X, et al. Ezrin regulates synovial angiogenesis in rheumatoid arthritis through YAP and Akt signalling. J Cell Mol Med. 2021;25(19):9378–9389. doi:10.1111/jcmm.16877
   PubMed Web of Science ®Google Scholar
• Bottini A, Wu DJ, Ai R, et al. PTPN14 phosphatase and YAP promote TGFbeta signalling in rheumatoid synoviocytes. Ann Rheum Dis. 2019;78(5):600–609. doi:10.1136/annrheumdis-2018-213799
   PubMed Web of Science ®Google Scholar
• Deng Y, Wu A, Li P, et al. Yap1 regulates multiple steps of chondrocyte differentiation during skeletal development and bone repair. Cell Rep. 2016;14(9):2224–2237. doi:10.1016/j.celrep.2016.02.021
   PubMed Web of Science ®Google Scholar
• Zhou W, Shen Q, Wang H, et al. Knockdown of YAP/TAZ inhibits the migration and invasion of fibroblast synovial cells in rheumatoid arthritis by regulating autophagy. J Immunol Res. 2020;2020:9510594. doi:10.1155/2020/9510594
   Web of Science ®Google Scholar
• Sacitharan PK. Ageing and Osteoarthritis. Subcell Biochem. 2019;91:123–159.
   PubMedGoogle Scholar
• Vanyai HK, Prin F, Guillermin O, et al. Control of skeletal morphogenesis by the Hippo-YAP/TAZ pathway. Development. 2020;1:147.
   Google Scholar
• Li Y, Yang S, Qin L, Yang S. TAZ is required for chondrogenesis and skeletal development. Cell Discov. 2021;7(1):26. doi:10.1038/s41421-021-00254-5
   Web of Science ®Google Scholar
• Sun K, Guo J, Guo Z, et al. The roles of the Hippo-YAP signalling pathway in cartilage and osteoarthritis. Ageing Res Rev. 2023;90:102015. doi:10.1016/j.arr.2023.102015
   Web of Science ®Google Scholar
• Gong Y, Li SJ, Liu R, et al. Inhibition of YAP with siRNA prevents cartilage degradation and ameliorates osteoarthritis development. J Mol Med. 2019;97(1):103–114. doi:10.1007/s00109-018-1705-y
   Web of Science ®Google Scholar
• Zhang X, Cai D, Zhou F, et al. Targeting downstream subcellular YAP activity as a function of matrix stiffness with Verteporfin-encapsulated chitosan microsphere attenuates osteoarthritis. Biomaterials. 2020;232:119724. doi:10.1016/j.biomaterials.2019.119724
   PubMed Web of Science ®Google Scholar
• Glasson SS, Chambers MG, Van Den Berg WB WB, Little CB. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthritis Cartilage. 2010;18(Suppl 3):S17–23. doi:10.1016/j.joca.2010.05.025
   PubMed Web of Science ®Google Scholar
• Tao SC, Yuan T, Zhang YL, Yin WJ, Guo SC, Zhang CQ. Exosomes derived from miR-140-5p-overexpressing human synovial mesenchymal stem cells enhance cartilage tissue regeneration and prevent osteoarthritis of the knee in a rat model. Theranostics. 2017;7(1):180–195. doi:10.7150/thno.17133
   PubMed Web of Science ®Google Scholar
• Zhang Q, Fang X, Zhao W, Liang Q. The transcriptional coactivator YAP1 is overexpressed in osteoarthritis and promotes its progression by interacting with Beclin-1. Gene. 2019;689:210–219. doi:10.1016/j.gene.2018.11.068
   Web of Science ®Google Scholar
• Yang B, Sun H, Song F, Yu M, Wu Y, Wang J. YAP1 negatively regulates chondrocyte differentiation partly by activating the beta-catenin signaling pathway. Int J Biochem Cell Biol. 2017;87:104–113. doi:10.1016/j.biocel.2017.04.007
   Web of Science ®Google Scholar
• Zhong W, Tian K, Zheng X, et al. Mesenchymal stem cell and chondrocyte fates in a multishear microdevice are regulated by Yes-associated protein. Stem Cells Dev. 2013;22(14):2083–2093. doi:10.1089/scd.2012.0685
   Web of Science ®Google Scholar
• Fu L, Hu Y, Song M, et al. Up-regulation of FOXD1 by YAP alleviates senescence and osteoarthritis. PLoS Biol. 2019;17(4):e3000201. doi:10.1371/journal.pbio.3000201
   Web of Science ®Google Scholar
• Lorthongpanich C, Charoenwongpaiboon T, Supakun P, Klaewkla M, Kheolamai P, Issaragrisil S. Fisetin inhibits osteogenic differentiation of mesenchymal stem cells via the inhibition of YAP. Antioxidants. 2021;5(10):10. doi:10.3390/antiox11010010
   Google Scholar
• Deng Y, Lu J, Li W, et al. Reciprocal inhibition of YAP/TAZ and NF-kappaB regulates osteoarthritic cartilage degradation. Nat Commun. 2018;9(1):4564. doi:10.1038/s41467-018-07022-2
   PubMed Web of Science ®Google Scholar
• Thorup AS, Strachan D, Caxaria S, et al. ROR2 blockade as a therapy for osteoarthritis. Sci Transl Med. 2020;2:12.
   Google Scholar
• Su S, Jiang W, Wang X, et al. Resolvin D1 inhibits the proliferation of osteoarthritis fibroblast-like synoviocytes through the Hippo-YAP signaling pathway. BMC Musculoskelet Disord. 2022;23(1):149. doi:10.1186/s12891-022-05095-1
   Web of Science ®Google Scholar
• Yang K, Wu Y, Cheng P, et al. YAP and ERK mediated mechanical strain-induced cell cycle progression through RhoA and cytoskeletal dynamics in rat growth plate chondrocytes. J Orthop Res. 2016;34(7):1121–1129. doi:10.1002/jor.23138
   Web of Science ®Google Scholar
• He J, Su X, Xie W. MiR-582-3p alleviates osteoarthritis progression by targeting YAP1. Mol Immunol. 2020;128:258–267. doi:10.1016/j.molimm.2020.10.022
   PubMed Web of Science ®Google Scholar
• Karystinou A, Roelofs AJ, Neve A, Cantatore FP, Wackerhage H, De bari C. Yes-associated protein (YAP) is a negative regulator of chondrogenesis in mesenchymal stem cells. Arthritis Res Ther. 2015;17(1):147. doi:10.1186/s13075-015-0639-9
   Google Scholar
• Jing X, Ye Y, Bao Y, et al. Mechano-growth factor protects against mechanical overload induced damage and promotes migration of growth plate chondrocytes through RhoA/YAP pathway. Exp Cell Res. 2018;366(2):81–91. doi:10.1016/j.yexcr.2018.02.021
   Web of Science ®Google Scholar
• Li M, Ning J, Wang J, Yan Q, Zhao K, Jia X. SETD7 regulates chondrocyte differentiation and glycolysis via the Hippo signaling pathway and HIF1alpha. Int J Mol Med. 2021;47(4):48. doi:10.3892/ijmm.2021.4881
   Google Scholar
• Jing X, Yang X, Zhang W, et al. Mechanical loading induces HIF-1alpha expression in chondrocytes via YAP. Biotechnol Lett. 2020;42(9):1645–1654. doi:10.1007/s10529-020-02910-4
   Web of Science ®Google Scholar
• Yu FF, Zuo J, Fu X, et al. Role of the hippo signaling pathway in the extracellular matrix degradation of chondrocytes induced by fluoride exposure. Ecotoxicol Environ Saf. 2021;225:112796. doi:10.1016/j.ecoenv.2021.112796
   Web of Science ®Google Scholar
• Nie P, Li Y, Suo H, Jiang N, Yu D, Fang B. Dasatinib promotes chondrogenic differentiation of human mesenchymal stem cells via the Src/Hippo-YAP signaling pathway. ACS Biomater Sci Eng. 2019;5(10):5255–5265. doi:10.1021/acsbiomaterials.9b00618
   PubMed Web of Science ®Google Scholar
• Li H, Li X, Jing X, et al. Hypoxia promotes maintenance of the chondrogenic phenotype in rat growth plate chondrocytes through the HIF-1alpha/YAP signaling pathway. Int J Mol Med. 2018;42(6):3181–3192. doi:10.3892/ijmm.2018.3921
   Web of Science ®Google Scholar
• Moya IM, Halder G. Hippo-YAP/TAZ signalling in organ regeneration and regenerative medicine. Nat Rev Mol Cell Biol. 2019;20(4):211–226. doi:10.1038/s41580-018-0086-y
   PubMed Web of Science ®Google Scholar
• Dupont S. Role of YAP/TAZ in cell-matrix adhesion-mediated signalling and mechanotransduction. Exp Cell Res. 2016;343(1):42–53. doi:10.1016/j.yexcr.2015.10.034
   PubMed Web of Science ®Google Scholar
• Koo JH, Guan KL. Interplay between YAP/TAZ and Metabolism. Cell Metab. 2018;28(2):196–206. doi:10.1016/j.cmet.2018.07.010
   PubMed Web of Science ®Google Scholar
• Bartel DP. Metazoan MicroRNAs. Cell. 2018;173(1):20–51. doi:10.1016/j.cell.2018.03.006
   PubMed Web of Science ®Google Scholar
• Cheng J, Li M, Bai R. The Wnt signaling cascade in the pathogenesis of osteoarthritis and related promising treatment strategies. Front Physiol. 2022;13:954454. doi:10.3389/fphys.2022.954454
   PubMed Web of Science ®Google Scholar
• Norouzi M, Yasamineh S, Montazeri M, et al. Recent advances on nanomaterials-based fluorimetric approaches for microRNAs detection. Mater Sci Eng C Mater Biol Appl. 2019;104:110007. doi:10.1016/j.msec.2019.110007
   PubMed Web of Science ®Google Scholar
• Wang SR, Chen X, Ling S, Ni RZ, Guo H, Xu JW. MicroRNA expression, targeting, release dynamics and early-warning biomarkers in acute cardiotoxicity induced by triptolide in rats. Biomed Pharmacother. 2019;111:1467–1477. doi:10.1016/j.biopha.2018.12.109
   Web of Science ®Google Scholar
• Cha S, Wang J, Lee SM, Tan Z, Zhao Q, Bai D. Clock-modified mesenchymal stromal cells therapy rescues molecular circadian oscillation and age-related bone loss via miR142-3p/Bmal1/YAP signaling axis. Cell Death Discov. 2022;8(1):111. doi:10.1038/s41420-022-00908-7
   Web of Science ®Google Scholar
• Yang JX, Xie P, Li YS, Wen T, Yang XC. Osteoclast-derived miR-23a-5p-containing exosomes inhibit osteogenic differentiation by regulating Runx2. Cell Signal. 2020;70:109504. doi:10.1016/j.cellsig.2019.109504
   PubMed Web of Science ®Google Scholar
• Woods A, Wang G, Beier F. Regulation of chondrocyte differentiation by the actin cytoskeleton and adhesive interactions. J Cell Physiol. 2007;213(1):1–8. doi:10.1002/jcp.21110
   PubMed Web of Science ®Google Scholar
• Xia B, Di C, Zhang J, Hu S, Jin H, Tong P. Osteoarthritis pathogenesis: a review of molecular mechanisms. Calcif Tissue Int. 2014;95(6):495–505. doi:10.1007/s00223-014-9917-9
   PubMed Web of Science ®Google Scholar
• Kania K, Colella F, Riemen AHK, et al. Regulation of Gdf5 expression in joint remodelling, repair and osteoarthritis. Sci Rep. 2020;10(1):157. doi:10.1038/s41598-019-57011-8
   Web of Science ®Google Scholar
• Ma T, Ruan H, Lv L, et al. Oleanolic acid, a small-molecule natural product, inhibits ECM degeneration in osteoarthritis by regulating the Hippo/YAP and Wnt/beta-catenin pathways. Food Funct. 2023;14(22):9999–10013. doi:10.1039/D3FO01902K
   Web of Science ®Google Scholar
• Wang X, Liao H, Liu Y, et al. Aspirin reverses inflammatory suppression of chondrogenesis by stabilizing YAP. Cell Prolif. 2023;56:e13380.
   Web of Science ®Google Scholar
• Chen R, Ying C, Zou Y, et al. Sarsasapogenin inhibits YAP1-dependent chondrocyte ferroptosis to alleviate osteoarthritis. Biomed Pharmacother. 2023;168:115772. doi:10.1016/j.biopha.2023.115772
   Web of Science ®Google Scholar
• Hao X, Zhao J, Jia L, et al. XMU-MP-1 attenuates osteoarthritis via inhibiting cartilage degradation and chondrocyte apoptosis. Front Bioeng Biotechnol. 2022;10:998077. doi:10.3389/fbioe.2022.998077
   Web of Science ®Google Scholar
• Feng X, Li S, Wang S, et al. Piezo1 mediates the degradation of cartilage extracellular matrix in malocclusion-induced TMJOA. Oral Dis. 2023. doi:10.1111/odi.14615
   Web of Science ®Google Scholar
• Liu R, Liu Z, Chen H, et al. Ginkgolide K delays the progression of osteoarthritis by regulating YAP to promote the formation of cartilage extracellular matrix. Phytother Res. 2023;37(11):5205–5222. doi:10.1002/ptr.7953
   Web of Science ®Google Scholar
• Ma XN, Feng W, Li N, et al. Leonurine alleviates rheumatoid arthritis by regulating the Hippo signaling pathway. Phytomedicine. 2023;123:155243. doi:10.1016/j.phymed.2023.155243
   Web of Science ®Google Scholar
• Barker BE, Hanlon MM, Marzaioli V, et al. The mammalian target of rapamycin contributes to synovial fibroblast pathogenicity in rheumatoid arthritis. Front Med. 2023;10:1029021. doi:10.3389/fmed.2023.1029021
   Web of Science ®Google Scholar
• Zhang Z, Wang Y, Xu Q, et al. Methyl Canthin-6-one-2-carboxylate Restrains the Migration/Invasion Properties of Fibroblast-like Synoviocytes by Suppressing the Hippo/YAP Signaling Pathway. Pharmaceuticals. 2023;17(1):16. doi:10.3390/ph17010016
   Google Scholar